524 related items for PubMed ID: 10468966
1. Growth hormone status following treatment for Cushing's syndrome.
Hughes NR, Lissett CA, Shalet SM.
Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
[Abstract] [Full Text] [Related]
2. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[Abstract] [Full Text] [Related]
3. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
Pecori Giraldi F, Andrioli M, De Marinis L, Bianchi A, Giampietro A, De Martin M, Sacco E, Scacchi M, Pontecorvi A, Cavagnini F.
Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
[Abstract] [Full Text] [Related]
4. Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.
Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F, Savage MO.
Clin Endocrinol (Oxf); 2004 Feb; 60(2):169-74. PubMed ID: 14725677
[Abstract] [Full Text] [Related]
5. How many tests are required to diagnose growth hormone (GH) deficiency in adults?
Lissett CA, Thompson EG, Rahim A, Brennan BM, Shalet SM.
Clin Endocrinol (Oxf); 1999 Nov; 51(5):551-7. PubMed ID: 10594515
[Abstract] [Full Text] [Related]
6. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.
Mukherjee A, Murray RD, Columb B, Gleeson HK, Shalet SM.
Clin Endocrinol (Oxf); 2003 Dec; 59(6):743-8. PubMed ID: 14974916
[Abstract] [Full Text] [Related]
7. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P, Boccardi E, Branca V, Bramerio M, Barberis M, Losa M, Terreni MT, Lodrini S, Pollo B, Vignati F.
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[Abstract] [Full Text] [Related]
8. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB, Turner HE, Adams CB, Wass JA.
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[Abstract] [Full Text] [Related]
9. Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
Tzanela M, Karavitaki N, Stylianidou C, Tsagarakis S, Thalassinos NC.
Clin Endocrinol (Oxf); 2004 Mar; 60(3):309-14. PubMed ID: 15008995
[Abstract] [Full Text] [Related]
10. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO.
J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
[Abstract] [Full Text] [Related]
11. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B.
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[Abstract] [Full Text] [Related]
12. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Estrada J, Boronat M, Mielgo M, Magallón R, Millan I, Díez S, Lucas T, Barceló B.
N Engl J Med; 1997 Jan 16; 336(3):172-7. PubMed ID: 8988897
[Abstract] [Full Text] [Related]
13. Results of external pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.
Vicente A, Estrada J, de la Cuerda C, Astigarraga B, Marazuela M, Blanco C, Lucas T, Barceló B.
Acta Endocrinol (Copenh); 1991 Nov 16; 125(5):470-4. PubMed ID: 1661997
[Abstract] [Full Text] [Related]
14. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.
Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP.
J Clin Endocrinol Metab; 1994 Jan 16; 78(1):131-7. PubMed ID: 7507118
[Abstract] [Full Text] [Related]
15. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome.
Leal-Cerro A, Venegas E, Garcia-Pesquera F, Jimenez LM, Astorga R, Casanueva FF, Dieguez C.
Clin Endocrinol (Oxf); 1998 Jan 16; 48(1):117-21. PubMed ID: 9509077
[Abstract] [Full Text] [Related]
16. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.
Kuwayama A, Kageyama N, Nakane T, Watanabe M, Kanie N.
J Clin Endocrinol Metab; 1981 Jul 16; 53(1):165-73. PubMed ID: 6263935
[Abstract] [Full Text] [Related]
17. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF.
Clin Endocrinol (Oxf); 1994 Nov 16; 41(5):649-54. PubMed ID: 7828354
[Abstract] [Full Text] [Related]
18. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome.
Leal-Cerro A, Pumar A, Villamil F, Astorga R, Dieguez C, Casanueva FF.
Clin Endocrinol (Oxf); 1993 Apr 16; 38(4):399-403. PubMed ID: 8319372
[Abstract] [Full Text] [Related]
19. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler GB.
J Clin Endocrinol Metab; 1987 Nov 16; 65(5):906-13. PubMed ID: 3499448
[Abstract] [Full Text] [Related]
20. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T, Tsushima T, Hizuka N, Odagiri E, Murata Y, Suda T, Takano K.
Endocr J; 2001 Feb 16; 48(1):53-62. PubMed ID: 11403103
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
